ID   13762 MAT B III
AC   CVCL_3475
SY   13762 Mat B III; 13762-MAT-B-III; MAT 13762; 13762; MatB 13762; Mat B-III; Mat B III; MatB
DR   CLO; CLO_0001076
DR   ATCC; CRL-1666
DR   BCRC; 60520
DR   ChEMBL-Cells; CHEMBL3308080
DR   ChEMBL-Targets; CHEMBL613867
DR   IZSLER; BS TCL 168
DR   PubChem_Cell_line; CVCL_3475
DR   Wikidata; Q54581749
RX   PubMed=1997182;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-392.html
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
RX   PubMed=1997182;
RA   Schecter, Robyn L.
RA   Woo, Annie
RA   Duong, Minn
RA   Batist, Gerald
RT   "In vivo and in vitro mechanisms of drug resistance in a rat mammary
RT   carcinoma model.";
RL   Cancer Res. 51:1434-1442(1991).
//